Speaker(s): 

James Dolezal, MD, Staff Member, Geisinger - has disclosures with SlideFlow Labs

Moderator: 

Rajiv Panikkar, MD - Staff Member- Geisinger - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the current landscape of FDA-cleared AI/ML medical devices and their clinical domains.
• Identify practical benefits and limitations of large language models and AI-based decision-support tools in clinical practice.
• Apply a structured checklist to evaluate AI solutions for safety, equity, and clinical utility within your own workflow.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Stefanie Leader, DO, Stanley Martin, MD, Dan Dometita, DO, Malachi Courtney, MD, Eric Hossler, DO, Stacey Coolbaugh, RDN, and Donald Weider, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Alison Mowery, DNP, CRNP, Timothy Murphy, MD

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None